Objective To appraise the data on systemic adverse effects of inhaled corticosteroids.
Methods A computerized database search from January 1, 1966, through July 31, 1998 …

Inhibitors of phosphodiesterase type 4 (PDE4) act by increasing intracellular concentrations
of cyclic AMP, which has a broad range of anti-inflammatory effects on various key effector …

Persistent ill health after acute COVID-19—referred to as long COVID, the post-acute COVID-
19 syndrome, or the post-COVID-19 condition—has emerged as a major concern. We …

Background Coronavirus disease 2019 (COVID-19) can manifest as a viral-induced
hyperinflammation with multiorgan involvement. Such patients often experience rapid …

ContextScotland prohibited smoking in confined public places on March 26, 2006.
ObjectiveTo investigate the association of smoke-free legislation with symptoms, pulmonary …

Objective To examine the effect of β blockers in the management of chronic obstructive
pulmonary disease (COPD), assessing their effect on mortality, hospital admissions, and …

Background Studies of patients admitted to hospital with COVID-19 have found varying
mortality outcomes associated with underlying respiratory conditions and inhaled …

Leukotriene-receptor antagonists are the first novel class of antiasthma drugs to become
available over the past three decades. They have an unique profile in that they are a hybrid …

Although inhaled and intranasal corticosteroids are first-line therapy for asthma and allergic
rhinitis, there has recently been an increasing awareness of their propensity to produce …

Study objective The inotropic, lusitropic, and electrophysiologic effects of acute hypercapnia
in humans are not known. Although the effects of hypercapnia on the systemic circulation …